Modern medical science achieves its next impressive technological breakthrough with the development of a unique biomedical tool called "lung on a chip". On July 27, 2025, leading researchers from an international consortium presented a revolutionary platform based on induced pluripotent stem cells (iPSCs).
The innovative technology allows precise modeling of human lung tissues, providing an unprecedented opportunity to observe viral interactions in real time. The microfluidic system emerges as an extremely promising tool for investigating potential therapies for diseases such as coronavirus and flu.
The key advantage of the new scientific approach is significantly reducing dependence on animal experimental models. The development opens new horizons for rapid testing of antiviral medications and vaccines, while promising more precise and ethical research practices.
The upcoming publication in a prestigious scientific journal will mark the beginning of a new stage in preventive medicine, providing innovative tools to counter future pandemic challenges.